PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Intuitive Surgical, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Intuitive Surgical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
  • Tangible Net Worth Ratio: Of every $100 of net worth, $98 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 88% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

$104

Over the last 3 years, every $100 of reported profit came with $104 of operating cash.

Lower than 83% of Healthcare companies in United States.

Self-Funding Ratio

2.7×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.7 times.

Higher than 77% of Healthcare companies in United States.

Cash Locked Ratio

$31

For every $100 of sales, $31 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $28 tied up three years earlier.

More money tied up than 68% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

$40

Sales grew 62% in 3 years; of every extra $100 of sales, $40 became extra profit.

Higher than 64% of Healthcare companies in United States.

Asset Productivity Ratio

+62% / +58%

In 3 years sales changed by +62% while total assets changed by +58%. Both moved at about the same pace.

Balance-sheet strength

Debt Due Cover Ratio

—

Data incomplete

Cash Cushion Ratio

—

Data incomplete

Tangible Assets Ratio

98%

Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 84% of Healthcare companies in United States.

Tangible Net Worth Ratio

98%

Of every $100 of net worth, $98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 88% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+1%

Share count rose 1% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 82% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Intuitive Surgical, Inc. owes $0.12 for every $1 it owns. Net profit rose 23% in the year to Dec 2025, and grew 29% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

53.7

Investors pay $53.7 for every $1 of Intuitive Surgical, Inc.'s yearly profit, higher than 83% of Healthcare companies in United States.

P/B ratio

8.63

The share price is 8.63 times Intuitive Surgical, Inc.'s book value per share, higher than 84% of Healthcare companies in United States.

Market cap

$156.8 B

The total market value of all of Intuitive Surgical, Inc.'s shares at today's price (share price × number of shares), larger than almost all Healthcare companies in United States. PosiCap size class: Tito Cap.

Net worth (book value)

$18.2 B

What Intuitive Surgical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$51.43

Net worth divided by the number of shares. The share price of $443.85 is 8.6 times this, which is the P/B above.

Return on equity (ROE)

17.9%

Intuitive Surgical, Inc. earned 17.9% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.

Owes vs Owns

0.12×

Intuitive Surgical, Inc. owes $0.12 for every $1 it owns (low), lower than 83% of Healthcare companies in United States.

Dividend yield

None

Intuitive Surgical, Inc. does not currently pay a dividend.

Revenue growth

+21%

Revenue rose 21% in the year to Dec 2025, and grew 17% a year on average over 3 years.

Profit growth

+23%

Net profit rose 23% in the year to Dec 2025, and grew 29% a year on average over 3 years.

Profit margin

28.4%

Intuitive Surgical, Inc. keeps $28 of every $100 of revenue as net profit.

Cash quality

1.06×

Cash from Intuitive Surgical, Inc.'s business was 1.06× its reported profit in the year to Dec 2025 — its profit turned into cash.

Questions

What is Intuitive Surgical, Inc.'s P/E ratio?

Investors pay $53.7 for every $1 of Intuitive Surgical, Inc.'s yearly profit, higher than 83% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Intuitive Surgical, Inc.: $156.8 B ÷ $18.2 B (30 Jun 2026) = 8.6.

What is Intuitive Surgical, Inc.'s return on equity?

Intuitive Surgical, Inc. earned 17.9% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.

How much does Intuitive Surgical, Inc. owe compared with what it owns?

Intuitive Surgical, Inc. owes $0.12 for every $1 it owns (low), lower than 83% of Healthcare companies in United States.

Does Intuitive Surgical, Inc. pay a dividend?

No. Intuitive Surgical, Inc. does not currently pay a dividend.

Is Intuitive Surgical, Inc.'s revenue growing?

Revenue rose 21% in the year to Dec 2025, and grew 17% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.